NCT06156865 Using Neuroimaging and Behavioral Assessments to Understand Late Talking
| NCT ID | NCT06156865 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Toronto |
| Condition | Developmental Language Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2024-01-19 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2024-01-19 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Late talkers (LT), representing 10-20% of children under 3, demonstrate hallmark syntax and vocabulary deficits similar to preschoolers with developmental language disorder. While effective and early interventions can mitigate the impact of late talking, not enough is known about its neural basis, yet is needed to inform the design of more individualized interventions. This proposed effort uses neuroimaging, along with behavioral methods, with the goal of better understanding the memory-language mechanisms that underlie learning and late talking, while also considering their association to treatment-related changes in LT.
Eligibility Criteria
Inclusion Criteria: * child and parent are monolingual/native (primarily) English speakers * child is enrolled at one of the participating facilities * child is recruited via word of mouth, including social media * child is between 18 and 30 months of age * child does not have any contraindications to magnetic resonance imaging (i.e., intracranial metal implants, claustrophobia) * child does not have any uncorrected vision challenges Exclusion Criteria: * Child does not meet criteria for LT or typical development * Standard magnetic resonance imaging exclusion criteria * Gestational age less than 37 weeks or greater than 42 weeks * Special education placement of child based on ability or behavior
Contact & Investigator
Karla N Washington, PhD
PRINCIPAL INVESTIGATOR
University of Toronto
Frequently Asked Questions
Who can join the NCT06156865 clinical trial?
This trial is open to participants of all sexes, aged 18 Months or older, up to 30 Months, studying Developmental Language Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06156865 currently recruiting?
Yes, NCT06156865 is actively recruiting participants. Contact the research team at karla.washington@utoronto.ca for enrollment information.
Where is the NCT06156865 trial being conducted?
This trial is being conducted at Oshawa, Canada, Toronto, Canada.
Who is sponsoring the NCT06156865 clinical trial?
NCT06156865 is sponsored by University of Toronto. The principal investigator is Karla N Washington, PhD at University of Toronto. The trial plans to enroll 45 participants.